BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS)

$0.77 -0.0217 (-2.7409%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 85

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS) News Sources

BCLI: Focused on Initiation of Phase 3b ENDURANCE Trial of NurOwn® in ALS…

15-08-2025

yahoo.com

BrainStorm Cell Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update

14-11-2025

yahoo.com

Global Amyotrophic Lateral Sclerosis Therapeutics Market Size/Share Worth USD 1964 Million by 2035 at 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

19-02-2026

yahoo.com

Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market

20-02-2026

yahoo.com

Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February

26-02-2026

yahoo.com

BrainStorm Cell Therapeutics Announces Full Year 2025 Financial Results and Provides Corporate Update

31-03-2026

yahoo.com

BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update

15-05-2026

yahoo.com

BrainStorm Cell Therapeutics Announces Aggregate of $400,000 in Private Placements Priced at Premium to Market

19-05-2026

yahoo.com

BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors

28-05-2026

yahoo.com

BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine

02-06-2026

yahoo.com

BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS) Sentiment Trend

0 25 50 75 100 89 85 81 90 90 78 86 82 89 81 15-08-2025 14-11-2025 19-02-2026 20-02-2026 26-02-2026 31-03-2026 15-05-2026 19-05-2026 28-05-2026 02-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS) FAQs

toggle

What is the current price of BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS)?

The current price of BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS) is $0.77.


toggle

BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS) absolute price change since previous trading day?

The absolute price change of BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS) since the previous trading day is $-0.0217.


toggle

BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS) percentage price change since previous trading day?

The percentage price change of BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS) since the previous trading day is -2.7409%.


toggle

What is the most recent average sentiment score for BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS)?

The most recent average sentiment score for BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS) is 85 out of 100.


toggle

What is the most recent average sentiment for BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS)?

The most recent sentiment for BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS) is .


SEC-8K** Filing Available For BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.